MD MPJE key terms

The state regulatory body that licenses pharmacists, pharmacy technicians, and pharmacies in Maryland, adopts regulations under the Pharmacy Practice Act, investigates complaints, and imposes discipline ranging from reprimand to license revocation.

Maryland's statute governing the practice of pharmacy, including licensure, prescription requirements, delegation, inspection authority, and grounds for disciplinary action; the Board adopts regulations to carry it out.

A negotiated disciplinary agreement between the Board and a licensee in which the licensee accepts specified sanctions, such as probation, monitoring, fines, or practice restrictions, without a full contested hearing.

An emergency Board action suspending a license before a full hearing when continued practice poses an immediate risk to public health and safety; a hearing must follow within a defined period.

Behavior that violates pharmacy standards or Board rules, such as practicing while impaired, falsifying records, dispensing without a valid prescription, or aiding unlicensed practice; it is a basis for discipline.

The credential issued by the Board authorizing an individual to practice pharmacy in Maryland after meeting education, internship, examination, and character requirements; it must be renewed on the Board's cycle.

The Board-issued credential allowing a person to perform delegated pharmacy tasks under pharmacist supervision; Maryland distinguishes certified technicians from non-certified pharmacy technicians with different training and scope expectations.

A Maryland registration required for a pharmacy located outside Maryland that ships prescription drugs to Maryland patients; it obligates compliance with Maryland labeling, counseling, and recordkeeping rules and Board inspection cooperation.

The Board-issued authorization for a physical location to operate as a pharmacy in Maryland; it specifies the pharmacist-in-charge and requires compliance with facility, security, and recordkeeping standards.

The pharmacist designated on a pharmacy permit as responsible for the pharmacy's day-to-day compliance, including supervision of personnel, security of drugs, recordkeeping, and correction of deficiencies found on inspection.

A pathway allowing a pharmacist licensed in another jurisdiction to obtain a Maryland license based on that existing license and qualifying credentials, subject to Board requirements such as examination or verification of good standing.

The periodic credit hours a Maryland pharmacist must earn to renew licensure, including any Board-mandated topic hours; records must be retained and produced on audit.

A Board credential permitting a pharmacy student or graduate to gain supervised practical experience toward licensure while performing pharmacist tasks under direct pharmacist supervision.

A lawful order for a drug issued by a practitioner acting in the usual course of practice, containing all required elements and not obtained by fraud, forgery, or misrepresentation; it is the legal basis for dispensing.

The information a dispensed container label must show, such as pharmacy identity, prescription number, patient name, drug name and strength, directions, quantity, date, prescriber, and required cautions or auxiliary labels.

The communication of prescription information between pharmacies so a patient may obtain refills elsewhere; it requires pharmacist-to-pharmacist or authorized electronic exchange and documentation of the transfer.

The prescriber's permission, stated on or added to a prescription, allowing a specified number of additional dispensings; refills beyond the authorized amount or expiration period require new authorization.

The requirement to maintain retrievable records of prescriptions dispensed, including the original order or its electronic image, refill history, and pharmacist verification, for the retention period set by Maryland and federal rules.

The classification of drugs under the federal Controlled Substances Act and Maryland law into Schedules I through V based on abuse potential and medical use; scheduling determines prescribing, dispensing, and recordkeeping rules.

A prescription for a scheduled drug that must meet additional requirements, such as prescriber DEA number, quantity limits, refill restrictions, and rules on oral versus written orders depending on the schedule.

Maryland's electronic database that collects dispensed controlled substance prescriptions so prescribers and pharmacists can review a patient's history; registration and query duties apply to covered dispensers and prescribers.

A controlled substance order system that lets registrants transmit Schedule II order forms electronically with digital signatures; it replaces paper DEA Form 222 while preserving accountability and recordkeeping.

The federal registration a practitioner or pharmacy must hold to handle controlled substances; it must be renewed periodically and kept at the registered location, and state authority is also required.

The pharmacist's discussion with a patient or caregiver about proper use, storage, interactions, and precautions for a dispensed drug; Maryland requires an offer to counsel with limited exceptions and documentation of refusals.

The oversight a pharmacist provides over delegated tasks performed by technicians and interns, including verification of filled prescriptions and availability for consultation; the degree of directness varies by task and setting.

The assignment of specific pharmacy functions to technicians or other personnel under pharmacist authority; tasks requiring professional judgment, such as final verification or counseling, cannot be delegated.

A written arrangement in which a pharmacist, under defined conditions, manages drug therapy for patients in cooperation with a prescriber, including adjusting or initiating therapy within the agreement's scope.

A pharmacy operating within a hospital or other licensed facility that dispenses to inpatients and staff; it follows distinct rules for drug distribution, floor stock, and pharmacist oversight of medication use.

A mechanical system that stores and dispenses drugs under pharmacist-controlled access, such as unit-based cabinets or outpatient kiosks; Maryland rules address labeling, security, and pharmacist review of overrides.

Transferring a drug from its original commercial container into another container for dispensing or distribution; it requires labeling, beyond-use dating, and records consistent with Board and USP standards.

Preparing sterile preparations such as injections and infusions using aseptic technique in a controlled environment; it demands validated processes, trained personnel, and environmental monitoring under USP standards adopted in Maryland.

The FDA's ranking of a recall as Class I, II, or III based on the health hazard posed; pharmacies must act on recall notices by quarantining, returning, or destroying affected stock and documenting the response.

The rules and licensed channel for sending unsold or expired drugs back through the supply chain; controlled substances require special handling, and returns to patients or resale of dispensed drugs are generally prohibited.

Federal standards protecting patients' protected health information, requiring pharmacies to limit disclosures, safeguard records, and apply minimum-necessary and business associate obligations alongside state confidentiality law.

The process of documenting and analyzing errors and near misses, internally and through required external programs, to identify causes and prevent recurrence; reporting is tied to quality improvement and patient safety.

A pharmacy's structured system for detecting, documenting, and learning from medication errors and near misses, including a defined quality-related event process and periodic review of trends to improve safety.

An entity that receives and analyzes patient safety work product under federal privilege protections, allowing pharmacies to share error data for learning while limiting certain discovery and disclosure.

A pharmacist's or technician's obligation to report certain events to the Board, such as arrests, disciplinary actions in other states, or suspected impairment, and to report suspected diversion or unprofessional conduct as required.